Skip to main content
Erschienen in: European Journal of Pediatrics 10/2015

01.10.2015 | Original Article

The clinical features of autoimmunity in 53 patients with Wiskott–Aldrich syndrome in China: a single-center study

verfasst von: Nan Chen, Zhi-Yong Zhang, Da-Wei Liu, Wei Liu, Xue-Mei Tang, Xiao-Dong Zhao

Erschienen in: European Journal of Pediatrics | Ausgabe 10/2015

Einloggen, um Zugang zu erhalten

Abstract

Autoimmune disease (AD) is common in patients with Wiskott-Aldrich syndrome (WAS) and patients with WAS who has an AD usually constitute a high-risk group with poor outcome. However, knowledge of AD in WAS is limited in China. In this study, medical records of 53 patients with WAS at Children´s Hospital of Chongqing Medical University from April 2004 to January 2014 were evaluated retrospectively and 14 patients (26%) had at least one AD. Autoimmune hemolytic anemia (AIHA) was the most common and detected in 12 patients (23%), other complications included immune thrombocytopenia (n = 1), immune neutropenia (n = 1), autoimmune arthritis (n = 1), and renal injury (n = 1). No significant differences were found in the level of serum immunoglobulins and lymphocyte subsets between the AD group and non-AD group. Although eight patients with AD received hematopoietic stem cell transplantation (HSCT), three patients died of pulmonary infection after HSCT.
Conclusions: AD is frequent in Chinese patients with WAS and AIHA was the most common. AD is a poor prognosis factor for WAS and should be treated as early as possible by HSCT.
What is Known:
• Autoimmune disease is common in patients with WAS.
• Manifestations, follow-up finding, and treatment approaches of autoimmune disease in Chinese patients with WAS have received less attention in the literature.
What is New:
• This study is firstly intended for evaluation of the clinical and immune characteristics of autoimmune disease in a large series Chinese patients with WAS.
• AD is frequent in Chinese patients with WAS and AIHA is the most common.
Literatur
1.
Zurück zum Zitat Aldrich RA, Steinberg AG, Campbell DC (1954) Pedigree demonstrating a sex-linked recessive condition characterized by draining ears, eczematoid dermatitis and bloody diarrhea. Pediatrics 13(2):133–139PubMed Aldrich RA, Steinberg AG, Campbell DC (1954) Pedigree demonstrating a sex-linked recessive condition characterized by draining ears, eczematoid dermatitis and bloody diarrhea. Pediatrics 13(2):133–139PubMed
2.
Zurück zum Zitat Azuma H, Oshima M, Ito K, Okuno A, Kawabata I, Banba K, Murahashi H, Sekine T, Kato Y, Ikebuchi K, Ikeda H (2000) Impaired interleukin-2 production in T-cells from a patient with Wiskott-Aldrich syndrome: basis of clinical effect of interleukin-2 replacement therapy. Eur J Pediatr 159(8):633–634CrossRefPubMed Azuma H, Oshima M, Ito K, Okuno A, Kawabata I, Banba K, Murahashi H, Sekine T, Kato Y, Ikebuchi K, Ikeda H (2000) Impaired interleukin-2 production in T-cells from a patient with Wiskott-Aldrich syndrome: basis of clinical effect of interleukin-2 replacement therapy. Eur J Pediatr 159(8):633–634CrossRefPubMed
3.
Zurück zum Zitat Beauparlant P, Papp K, Haraoui B (1999) The incidence of cancer associated with the treatment of rheumatoid arthritis. Semin Arthritis Rheum 29(3):148–158CrossRefPubMed Beauparlant P, Papp K, Haraoui B (1999) The incidence of cancer associated with the treatment of rheumatoid arthritis. Semin Arthritis Rheum 29(3):148–158CrossRefPubMed
4.
Zurück zum Zitat Bosticardo M, Marangoni F, Aiuti A, Villa A, Grazia Roncarolo M (2009) Recent advances in understanding the pathophysiology of Wiskott-Aldrich syndrome. Blood 113(25):6288–6295CrossRefPubMed Bosticardo M, Marangoni F, Aiuti A, Villa A, Grazia Roncarolo M (2009) Recent advances in understanding the pathophysiology of Wiskott-Aldrich syndrome. Blood 113(25):6288–6295CrossRefPubMed
5.
Zurück zum Zitat Cleland SY, Siegel RM (2011) Wiskott-Aldrich syndrome at the nexus of autoimmune and primary immunodeficiency diseases. FEBS Let 585(23):3710–3714CrossRef Cleland SY, Siegel RM (2011) Wiskott-Aldrich syndrome at the nexus of autoimmune and primary immunodeficiency diseases. FEBS Let 585(23):3710–3714CrossRef
6.
Zurück zum Zitat Dupuis-Girod S, Medioni J, Haddad E, Quartier P, Cavazzana-Calvo M, Le Deist F, de Saint Basile G, Delaunay J, Schwarz K, Casanova JL, Blanche S, Fischer A (2003) Autoimmunity in Wiskott-Aldrich syndrome: risk factors, clinical features, and outcome in a single-center cohort of 55 patients. Pediatrics 111(5 Pt 1):e622–e627CrossRefPubMed Dupuis-Girod S, Medioni J, Haddad E, Quartier P, Cavazzana-Calvo M, Le Deist F, de Saint Basile G, Delaunay J, Schwarz K, Casanova JL, Blanche S, Fischer A (2003) Autoimmunity in Wiskott-Aldrich syndrome: risk factors, clinical features, and outcome in a single-center cohort of 55 patients. Pediatrics 111(5 Pt 1):e622–e627CrossRefPubMed
7.
Zurück zum Zitat Duzova A, Topaloglu R, Sanal O, Kilic S, Mazza C, Besbas N, Bakkaloglu A (2001) Henoch-Schönlein purpura in Wiskott-Aldrich syndrome. Pediatr Nephrol 16(6):500–502CrossRefPubMed Duzova A, Topaloglu R, Sanal O, Kilic S, Mazza C, Besbas N, Bakkaloglu A (2001) Henoch-Schönlein purpura in Wiskott-Aldrich syndrome. Pediatr Nephrol 16(6):500–502CrossRefPubMed
8.
Zurück zum Zitat Farh KK, Marson A, Zhu J, Kleinewietfeld M, Housley WJ, Beik S, Shoresh N, Whitton H, Ryan RJ, Shishkin AA, Hatan M, Carrasco-Alfonso MJ, Mayer D, Luckey CJ, Patsopoulos NA, De Jager PL, Kuchroo VK, Epstein CB, Daly MJ, Hafler DA, Bernstein BE (2014) Genetic and epigenetic fine mapping of causal autoimmune disease variants. Nature. doi:10.1038/nature13835 PubMed Farh KK, Marson A, Zhu J, Kleinewietfeld M, Housley WJ, Beik S, Shoresh N, Whitton H, Ryan RJ, Shishkin AA, Hatan M, Carrasco-Alfonso MJ, Mayer D, Luckey CJ, Patsopoulos NA, De Jager PL, Kuchroo VK, Epstein CB, Daly MJ, Hafler DA, Bernstein BE (2014) Genetic and epigenetic fine mapping of causal autoimmune disease variants. Nature. doi:10.​1038/​nature13835 PubMed
9.
Zurück zum Zitat Hoshino A, Shimizu M, Matsukura H, Sakaki-Nakatsubo H, Nomura K, Miyawaki T, Kanegane H (2014) Allogeneic bone marrow transplantation appears to ameliorate IgA nephropathy in a patient with X-linked thrombocytopenia. J Clin Immunol 34(1):53–57CrossRefPubMed Hoshino A, Shimizu M, Matsukura H, Sakaki-Nakatsubo H, Nomura K, Miyawaki T, Kanegane H (2014) Allogeneic bone marrow transplantation appears to ameliorate IgA nephropathy in a patient with X-linked thrombocytopenia. J Clin Immunol 34(1):53–57CrossRefPubMed
10.
Zurück zum Zitat Imai K, Morio T, Zhu Y, Jin Y, Itoh S, Kajiwara M, Yata J, Mizutani S, Ochs HD, Nonoyama S (2004) Clinical course of patients with WASP gene mutations. Blood 103(2):456–464CrossRefPubMed Imai K, Morio T, Zhu Y, Jin Y, Itoh S, Kajiwara M, Yata J, Mizutani S, Ochs HD, Nonoyama S (2004) Clinical course of patients with WASP gene mutations. Blood 103(2):456–464CrossRefPubMed
11.
Zurück zum Zitat Kim JJ, Thrasher AJ, Jones AM, Davies EG, Cale CM (2007) Rituximab for the treatment of autoimmune cytopenias in children with immunedeficiency. Br J Haematol 138(1):94–96CrossRefPubMed Kim JJ, Thrasher AJ, Jones AM, Davies EG, Cale CM (2007) Rituximab for the treatment of autoimmune cytopenias in children with immunedeficiency. Br J Haematol 138(1):94–96CrossRefPubMed
12.
Zurück zum Zitat Latal Hajnal B, Lips U, Friedrich W, Zachmann M, Berthet F (1995) Addison disease 10 years after bone marrow transplantation for Wiskott-Aldrich syndrome. Eur J Pediatr 154(9):729–731CrossRefPubMed Latal Hajnal B, Lips U, Friedrich W, Zachmann M, Berthet F (1995) Addison disease 10 years after bone marrow transplantation for Wiskott-Aldrich syndrome. Eur J Pediatr 154(9):729–731CrossRefPubMed
13.
Zurück zum Zitat Lee WI, Yang CY, Jaing TH, Huang JL, Chien YH, Chang KW (2008) Clinical aspects and molecular analysis of Chinese patients with Wiskott-Aldrich syndrome in Taiwan. Int Arch Allergy Immunol 145(1):15–23CrossRefPubMed Lee WI, Yang CY, Jaing TH, Huang JL, Chien YH, Chang KW (2008) Clinical aspects and molecular analysis of Chinese patients with Wiskott-Aldrich syndrome in Taiwan. Int Arch Allergy Immunol 145(1):15–23CrossRefPubMed
14.
Zurück zum Zitat Matsukura H, Kanegane H, Miya K, Ohtsubo K, Higuchi A, Tanizawa T, Miyawaki T (2004) IgA nephropathy associated with X-linked thrombocytopenia. Am J Kidney Dis 43(3):e7–e12CrossRefPubMed Matsukura H, Kanegane H, Miya K, Ohtsubo K, Higuchi A, Tanizawa T, Miyawaki T (2004) IgA nephropathy associated with X-linked thrombocytopenia. Am J Kidney Dis 43(3):e7–e12CrossRefPubMed
15.
Zurück zum Zitat Maillard MH, Cotta-de-Almeida V, Takeshima F, Nguyen DD, Michetti P, Nagler C, Bhan AK, Snapper SB (2007) The Wiskott-Aldrich syndrome protein is required for the function of CD4(+)CD25(+)Foxp3(+) regulatory T cells. J Exp Med 204(2):381–391PubMedCentralCrossRefPubMed Maillard MH, Cotta-de-Almeida V, Takeshima F, Nguyen DD, Michetti P, Nagler C, Bhan AK, Snapper SB (2007) The Wiskott-Aldrich syndrome protein is required for the function of CD4(+)CD25(+)Foxp3(+) regulatory T cells. J Exp Med 204(2):381–391PubMedCentralCrossRefPubMed
16.
Zurück zum Zitat Massaad MJ, Ramesh N, Geha R (2013) Wiskott-Aldrich syndrome: a comprehensive review. Ann N Y Acad Sci 1285:26–43CrossRefPubMed Massaad MJ, Ramesh N, Geha R (2013) Wiskott-Aldrich syndrome: a comprehensive review. Ann N Y Acad Sci 1285:26–43CrossRefPubMed
17.
Zurück zum Zitat Mahlaoui N, Pellier I, Mignot C, Jais JP, Bilhou-Nabéra C, Moshous D, Neven B, Picard C, de Saint-Basile G, Cavazzana-Calvo M, Blanche S, Fischer A (2013) Characteristics and outcome of early-onset, severe forms of Wiskott-Aldrich syndrome. Blood 121(9):1510–1516CrossRefPubMed Mahlaoui N, Pellier I, Mignot C, Jais JP, Bilhou-Nabéra C, Moshous D, Neven B, Picard C, de Saint-Basile G, Cavazzana-Calvo M, Blanche S, Fischer A (2013) Characteristics and outcome of early-onset, severe forms of Wiskott-Aldrich syndrome. Blood 121(9):1510–1516CrossRefPubMed
18.
Zurück zum Zitat Notarangelo LD, Miao CH, Ochs HD (2008) Wiskott-Aldrich syndrome. Curr Opin Hematol 15(1):30–36CrossRefPubMed Notarangelo LD, Miao CH, Ochs HD (2008) Wiskott-Aldrich syndrome. Curr Opin Hematol 15(1):30–36CrossRefPubMed
19.
Zurück zum Zitat Patiroglu T, Gungor HE, Unal E (2012) Autoimmune diseases detected in children with primary immunodeficiency diseases: results from a reference centre at Middle Anatolia. Acta Microbiol Immunol Hung 59(3):343–353CrossRefPubMed Patiroglu T, Gungor HE, Unal E (2012) Autoimmune diseases detected in children with primary immunodeficiency diseases: results from a reference centre at Middle Anatolia. Acta Microbiol Immunol Hung 59(3):343–353CrossRefPubMed
20.
Zurück zum Zitat Pessach IM (2010) The relationship of x-linked primary immune deficiencies and autoimmunity. Curr Allergy Asthma Rep 10(5):311–319CrossRefPubMed Pessach IM (2010) The relationship of x-linked primary immune deficiencies and autoimmunity. Curr Allergy Asthma Rep 10(5):311–319CrossRefPubMed
21.
Zurück zum Zitat Sallah S, Wan JY, Hanrahan LR (2001) Future development of lymphoproliferative disorders in patients with autoimmune hemolytic anemia. Clin Cancer Res 7(4):791–794PubMed Sallah S, Wan JY, Hanrahan LR (2001) Future development of lymphoproliferative disorders in patients with autoimmune hemolytic anemia. Clin Cancer Res 7(4):791–794PubMed
22.
Zurück zum Zitat Schurman SH, Candotti F (2003) Autoimmunity in Wiskott-Aldrich syndrome. Curr Opin Rheumatol 15(4):446–453CrossRefPubMed Schurman SH, Candotti F (2003) Autoimmunity in Wiskott-Aldrich syndrome. Curr Opin Rheumatol 15(4):446–453CrossRefPubMed
23.
Zurück zum Zitat Shimizu M, Kanegane H, Wada T, Motoyoshi Y, Morio T, Candotti F, Yachie A (2013) Aberrant glycosylation of IgA in Wiskott-Aldrich syndrome and X-linked thrombocytopenia. J Allergy Clin Immunol 131(2):587–90.e1-3PubMedCentralCrossRefPubMed Shimizu M, Kanegane H, Wada T, Motoyoshi Y, Morio T, Candotti F, Yachie A (2013) Aberrant glycosylation of IgA in Wiskott-Aldrich syndrome and X-linked thrombocytopenia. J Allergy Clin Immunol 131(2):587–90.e1-3PubMedCentralCrossRefPubMed
24.
Zurück zum Zitat Shin CR, Kim MO, Li D, Bleesing JJ, Harris R, Mehta P, Jodele S, Jordan MB, Marsh RA, Davies SM, Filipovich AH (2012) Outcomes following hematopoietic cell transplantation for Wiskott-Aldrich syndrome. Bone Marrow Transplant 47(11):1428–1435CrossRefPubMed Shin CR, Kim MO, Li D, Bleesing JJ, Harris R, Mehta P, Jodele S, Jordan MB, Marsh RA, Davies SM, Filipovich AH (2012) Outcomes following hematopoietic cell transplantation for Wiskott-Aldrich syndrome. Bone Marrow Transplant 47(11):1428–1435CrossRefPubMed
25.
Zurück zum Zitat Shimizu M, Nikolov NP, Ueno K, Ohta K, Siegel RM, Yachie A, Candotti F (2012) Development of IgA nephropathy-like glomerulonephritis associated with Wiskott-Aldrich syndrome protein deficiency. Clin Immunol 142(2):160–166PubMedCentralCrossRefPubMed Shimizu M, Nikolov NP, Ueno K, Ohta K, Siegel RM, Yachie A, Candotti F (2012) Development of IgA nephropathy-like glomerulonephritis associated with Wiskott-Aldrich syndrome protein deficiency. Clin Immunol 142(2):160–166PubMedCentralCrossRefPubMed
26.
Zurück zum Zitat ten Bensel RW, Stadlan EM, Krivit W (1966) The development of malignancy in the course of the Aldrich syndrome. J Pediatr 68(5):761–767CrossRefPubMed ten Bensel RW, Stadlan EM, Krivit W (1966) The development of malignancy in the course of the Aldrich syndrome. J Pediatr 68(5):761–767CrossRefPubMed
27.
Zurück zum Zitat Webb MC, Andrews PA, Koffman CG, Cameron JS (1993) Renal transplantation in Wiskott-Aldrich syndrome. Transplantation 56(6):1585PubMed Webb MC, Andrews PA, Koffman CG, Cameron JS (1993) Renal transplantation in Wiskott-Aldrich syndrome. Transplantation 56(6):1585PubMed
28.
Zurück zum Zitat Worth AJ, Booth C, Veys P (2013) Stem cell transplantation for primary immune deficiency. Curr Opin Hematol 20(6):501–508CrossRefPubMed Worth AJ, Booth C, Veys P (2013) Stem cell transplantation for primary immune deficiency. Curr Opin Hematol 20(6):501–508CrossRefPubMed
Metadaten
Titel
The clinical features of autoimmunity in 53 patients with Wiskott–Aldrich syndrome in China: a single-center study
verfasst von
Nan Chen
Zhi-Yong Zhang
Da-Wei Liu
Wei Liu
Xue-Mei Tang
Xiao-Dong Zhao
Publikationsdatum
01.10.2015
Verlag
Springer Berlin Heidelberg
Erschienen in
European Journal of Pediatrics / Ausgabe 10/2015
Print ISSN: 0340-6199
Elektronische ISSN: 1432-1076
DOI
https://doi.org/10.1007/s00431-015-2527-3

Weitere Artikel der Ausgabe 10/2015

European Journal of Pediatrics 10/2015 Zur Ausgabe

Neuer Typ-1-Diabetes bei Kindern am Wochenende eher übersehen

23.04.2024 Typ-1-Diabetes Nachrichten

Wenn Kinder an Werktagen zum Arzt gehen, werden neu auftretender Typ-1-Diabetes und diabetische Ketoazidosen häufiger erkannt als bei Arztbesuchen an Wochenenden oder Feiertagen.

Neue Studienergebnisse zur Myopiekontrolle mit Atropin

22.04.2024 Fehlsichtigkeit Nachrichten

Augentropfen mit niedrig dosiertem Atropin können helfen, das Fortschreiten einer Kurzsichtigkeit bei Kindern zumindest zu verlangsamen, wie die Ergebnisse einer aktuellen Studie mit verschiedenen Dosierungen zeigen.

Spinale Muskelatrophie: Neugeborenen-Screening lohnt sich

18.04.2024 Spinale Muskelatrophien Nachrichten

Seit 2021 ist die Untersuchung auf spinale Muskelatrophie Teil des Neugeborenen-Screenings in Deutschland. Eine Studie liefert weitere Evidenz für den Nutzen der Maßnahme.

Fünf Dinge, die im Kindernotfall besser zu unterlassen sind

18.04.2024 Pädiatrische Notfallmedizin Nachrichten

Im Choosing-Wisely-Programm, das für die deutsche Initiative „Klug entscheiden“ Pate gestanden hat, sind erstmals Empfehlungen zum Umgang mit Notfällen von Kindern erschienen. Fünf Dinge gilt es demnach zu vermeiden.

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.